Janney Montgomery Scott LLC Sells 1,583 Shares of HCA Healthcare Inc (NYSE:HCA)

Janney Montgomery Scott LLC cut its stake in HCA Healthcare Inc (NYSE:HCA) by 11.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,132 shares of the company’s stock after selling 1,583 shares during the quarter. Janney Montgomery Scott LLC’s holdings in HCA Healthcare were worth $1,461,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Steward Partners Investment Advisory LLC raised its position in shares of HCA Healthcare by 2.1% in the second quarter. Steward Partners Investment Advisory LLC now owns 3,940 shares of the company’s stock valued at $532,000 after purchasing an additional 82 shares during the period. Cornerstone Advisors Inc. increased its position in HCA Healthcare by 15.0% during the second quarter. Cornerstone Advisors Inc. now owns 675 shares of the company’s stock worth $91,000 after acquiring an additional 88 shares during the period. Cibc Bank USA increased its position in HCA Healthcare by 1.7% during the third quarter. Cibc Bank USA now owns 5,656 shares of the company’s stock worth $681,000 after acquiring an additional 96 shares during the period. NEXT Financial Group Inc increased its position in HCA Healthcare by 32.1% during the third quarter. NEXT Financial Group Inc now owns 424 shares of the company’s stock worth $51,000 after acquiring an additional 103 shares during the period. Finally, AE Wealth Management LLC increased its position in HCA Healthcare by 0.7% during the second quarter. AE Wealth Management LLC now owns 18,115 shares of the company’s stock worth $2,449,000 after acquiring an additional 126 shares during the period. 70.19% of the stock is currently owned by institutional investors.

HCA stock opened at $136.21 on Friday. HCA Healthcare Inc has a 12 month low of $110.31 and a 12 month high of $147.42. The firm has a market cap of $45.57 billion, a P/E ratio of 13.94, a P/E/G ratio of 1.14 and a beta of 0.90. The company’s 50-day moving average price is $124.06 and its two-hundred day moving average price is $127.23.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 29th. The company reported $2.23 EPS for the quarter, beating the consensus estimate of $2.13 by $0.10. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The firm had revenue of $12.69 billion for the quarter, compared to analyst estimates of $12.48 billion. During the same period last year, the firm earned $2.16 EPS. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. As a group, equities research analysts forecast that HCA Healthcare Inc will post 10.52 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 2nd will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.17%. The ex-dividend date is Friday, November 29th. HCA Healthcare’s dividend payout ratio is currently 16.38%.

In other HCA Healthcare news, SVP Deborah M. Reiner sold 749 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $136.67, for a total value of $102,365.83. Following the transaction, the senior vice president now directly owns 8,237 shares of the company’s stock, valued at approximately $1,125,750.79. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Kathleen M. Whalen sold 977 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $127.56, for a total transaction of $124,626.12. Following the completion of the transaction, the senior vice president now directly owns 11,484 shares in the company, valued at $1,464,899.04. The disclosure for this sale can be found here. Over the last three months, insiders sold 39,553 shares of company stock worth $5,282,165. Insiders own 2.70% of the company’s stock.

HCA has been the topic of a number of recent research reports. UBS Group raised their price target on shares of HCA Healthcare from $165.00 to $168.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. ValuEngine raised shares of HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Stephens set a $150.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Bank of America raised shares of HCA Healthcare from an “underperform” rating to a “neutral” rating and raised their price target for the stock from $130.00 to $137.00 in a research report on Friday, September 6th. Finally, Barclays raised their price target on shares of HCA Healthcare from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $155.07.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Why is the price-sales ratio important?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply